Literature DB >> 21716087

Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity.

Alena Skalova1, Radek Sima, Jana Kaspirkova-Nemcova, Roderick H W Simpson, Goran Elmberger, Ilmo Leivo, Silvana Di Palma, Tomas Jirasek, Douglas R Gnepp, Ilan Weinreb, Bayardo Perez-Ordoñez, Petr Mukensnabl, Boris Rychly, Petr Hrabal, Michal Michal.   

Abstract

We present a series of 23 cases of a distinctive, hitherto poorly recognized low-grade adenocarcinoma, with several histologic features reminiscent of papillary carcinoma of the thyroid, and which mostly but not exclusively occurs in the tongue. All the tumors were unencapsulated and were divided into lobules that were composed mainly of cribriform and solid growth patterns. Therefore, we propose the name "cribriform adenocarcinoma of minor salivary gland origin (CAMSG)." All the patients were adults with a mean age at diagnosis of 55.8 years (range, 25 to 85 y). Fourteen of the 23 tumors were localized in the tongue, 3 in the soft palate, 2 in the retromolar buccal mucosa, 3 in the lingual tonsils, and 1 in the upper lip. Fifteen patients of 23 had synchronous metastases in the cervical lymph nodes at the time of diagnosis, bilateral in 3 cases. In 3 patients, the nodal metastasis was the first evidence of disease, later investigation revealing primary neoplasms in the base of tongue and tonsil, respectively. In addition, 1 patient developed a cervical lymph node metastasis 8 years after excision of a primary tumor of the tongue. Data on treatment and follow-up were available in 14 cases. The patients were treated by radical excision with clear margins (12 cases) or by simple excision (2 cases). Neck dissection was performed in 10 patients; 9 received radiotherapy, but none were treated by chemotherapy. Clinical follow-up ranged from 2 months to 13 years (mean, 6 y and 5 mo). Twelve patients are alive with no evidence of recurrent or metastatic disease after treatment, 1 patient died 2 years after surgery without evidence of tumor, and 1 patient is alive with recurrent tumor of the palate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21716087     DOI: 10.1097/PAS.0b013e31821e1f54

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  Factors that may influence polymorphous low-grade adenocarcinoma growth.

Authors:  Andresa Borges Soares; Elizabeth Ferreira Martinez; Patricia Fernandes Avila Ribeiro; Icleia Siqueira Barreto; Maria Cássia Aguiar; Cristiane Furuse; Marcelo Sperandio; Victor Angelo Montalli; Ney Soares de Araújo; Vera Cavalcanti de Araújo
Journal:  Virchows Arch       Date:  2017-02-10       Impact factor: 4.064

Review 2.  Basaloid/blue salivary gland tumors.

Authors:  Raja R Seethala
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

Review 3.  Newly described salivary gland tumors.

Authors:  Alena Skalova; Michal Michal; Roderick Hw Simpson
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

4.  Salivary gland tumor "wishes" to add to the next WHO Tumor Classification: sclerosing polycystic adenosis, mammary analogue secretory carcinoma, cribriform adenocarcinoma of the tongue and other sites, and mucinous variant of myoepithelioma.

Authors:  Douglas R Gnepp
Journal:  Head Neck Pathol       Date:  2014-03-05

5.  Secretory myoepithelial carcinoma: a histologic and molecular survey and a proposed nomenclature for mucin producing signet ring tumors.

Authors:  Jassem M Bastaki; Bibianna M Purgina; Sanja Dacic; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2014-01-21

6.  Cribriform adenocarcinoma of minor salivary glands may express galectin-3, cytokeratin 19, and HBME-1 and contains polymorphisms of RET and H-RAS proto-oncogenes.

Authors:  Jan Laco; Kateřina Kamarádová; Pavla Vítková; Eva Sehnálková; Sárka Dvořáková; Eliška Václavíková; Vlasta Sýkorová; Jana Kašpírková; Alena Skálová; Aleš Ryška
Journal:  Virchows Arch       Date:  2012-09-28       Impact factor: 4.064

Review 7.  [Updates on tumours of the salivary glands : 2017 WHO classification].

Authors:  S Ihrler; O Guntinas-Lichius; C Haas; M Mollenhauer
Journal:  Pathologe       Date:  2018-02       Impact factor: 1.011

8.  Predictors of Outcome in the Phenotypic Spectrum of Polymorphous Low-grade Adenocarcinoma (PLGA) and Cribriform Adenocarcinoma of Salivary Gland (CASG): A Retrospective Study of 69 Patients.

Authors:  Bin Xu; Amandeep Aneja; Ronald Ghossein; Nora Katabi
Journal:  Am J Surg Pathol       Date:  2016-11       Impact factor: 6.394

Review 9.  Recent advances in the diagnostic pathology of salivary carcinomas.

Authors:  Roderick H W Simpson; Alena Skálová; Silvana Di Palma; Ilmo Leivo
Journal:  Virchows Arch       Date:  2014-08-30       Impact factor: 4.064

Review 10.  Polymorphous adenocarcinoma of the salivary glands: reappraisal and update.

Authors:  Vincent Vander Poorten; Asterios Triantafyllou; Alena Skálová; Göran Stenman; Justin A Bishop; Esther Hauben; Jennifer L Hunt; Henrik Hellquist; Simon Feys; Remco De Bree; Antti A Mäkitie; Miquel Quer; Primož Strojan; Orlando Guntinas-Lichius; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-14       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.